Literature DB >> 10828866

Unrelated bone marrow transplantation in children: outcome and a comparison with sibling donor grafting.

A Gustafsson1, M Remberger, J Winiarski, O Ringdén.   

Abstract

The clinical course of 59 children, who underwent BMT during 1988-1998 with a matched unrelated donor (MUD), was compared with 59 case controls receiving a sibling donor marrow. Thirty-eight patients had haematological malignancies while 21 had a nonmalignant disorder. The cumulative incidence of acute GVHD grade II-IV was 28% for MUD recipients vs 11% (P = 0.014) for sibling recipients. Extensive chronic GVHD was rare in both groups. The 5-year probability of survival was 52% for MUD vs 77% for sibling recipients (P= 0.014). For children with malignancies the 4-year probability of survival was 52% for MUD vs 67% for sibling recipients with a RFS of 49% vs 62%. In the ALL patients the survival of the MUD recipients was 77% and equalled that of the sibling group. For SAA survival was 43% vs 86% (P = 0.09) and for metabolic disorders 63% vs 89% (P = 0.025). The transplant-related mortality was higher in the MUD group, while death due to relapse was equally distributed. These results of MUD BMT in children compare favourably with most previous reports, and support the use of alternative donors in cases who lack an HLA-identical siblings. Bone Marrow Transplantation (2000).

Entities:  

Mesh:

Year:  2000        PMID: 10828866     DOI: 10.1038/sj.bmt.1702400

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  5 in total

Review 1.  Survival of the fittest: in vivo selection and stem cell gene therapy.

Authors:  Tobias Neff; Brian C Beard; Hans-Peter Kiem
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

2.  Unrelated donor marrow transplantation for congenital immunodeficiency and metabolic disease: an update of the experience of the Japan Marrow Donor Program.

Authors:  Naoki Sakata; Keisei Kawa; Koji Kato; Hiromasa Yabe; Miharu Yabe; Masayuki Nagasawa; Hideo Mugishima; Hisato Kigasawa; Masahiro Tsuchida; Yuichi Akiyama; Yasuo Morisima; Yoshihisa Kodera; Shunichi Kato
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

3.  Outcome after relapse in childhood acute lymphoblastic leukemia.

Authors:  Keiko Yumura-Yagi; Junichi Hara; Keizo Horibe; Akio Tawa; Yoshihiro Komada; Megumi Oda; Shinichiro Nishimura; Makoto Yoshida; Tooru Kudo; Kazuhiro Ueda
Journal:  Int J Hematol       Date:  2002-07       Impact factor: 2.490

Review 4.  Risk assessment in haematopoietic stem cell transplantation: histocompatibility.

Authors:  Effie W Petersdorf
Journal:  Best Pract Res Clin Haematol       Date:  2007-06       Impact factor: 3.020

5.  Outcome of unrelated donor stem cell transplantation for children with severe aplastic anemia.

Authors:  Evelio D Perez-Albuerne; Mary Eapen; John Klein; Thomas J Gross; Jeffery M Lipton; K Scott Baker; Anne Woolfrey; Naynesh Kamani
Journal:  Br J Haematol       Date:  2008-02-26       Impact factor: 6.998

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.